awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46182874-06288C79-72B4-414E-BBC0-D2FADCB1266C
Q46182874-06288C79-72B4-414E-BBC0-D2FADCB1266C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46182874-06288C79-72B4-414E-BBC0-D2FADCB1266C
New therapeutics in primary biliary cirrhosis: will there ever be light?
P2860
Q46182874-06288C79-72B4-414E-BBC0-D2FADCB1266C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46182874-06288C79-72B4-414E-BBC0-D2FADCB1266C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
feaa54c2e867c9202aaeb1199c43d0b99754a851
P2860
Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.